Detection of hypopharyngeal squamous cell carcinoma using serum proteomics

References

• Eckel HE, Staar S, Volling P, Sittel C, Damm M, Jungehuelsing M. Surgical treatment for hypopharynx carcinoma. Feasibility, mortality, and results. Otolaryngol Head Neck Surg 2001; 124: 561–9
   PubMed Web of Science ®Google Scholar
• Hoffman HT, Karnell LH, Shah JP, Ariyan S, Brown GS, Fee WE, et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope 1997; 107: 1005–17
   PubMed Web of Science ®Google Scholar
• Tang PZ, Tu GY. Surgical approaches and comprehensive treatment of hypopharyngeal cancer. Zhong Hua Er Bi Yan Hou Ke Za Zhi 1992; 27(Suppl)17–19
   PubMedGoogle Scholar
• Srinivas PR, Srivastava S, Hanash S, Wright GL, Jr. Proteomics in early detection of cancer. Clin Chem 2001; 47: 1901–11
   PubMed Web of Science ®Google Scholar
• Adam BL, Vlahou A, Semmes OJ, Wright GLJ. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics 2001; 1: 1264–70
   PubMed Web of Science ®Google Scholar
• von Eggeling F, Junker K, Fiedle W, Wollscheid V, Durst M, Claussen U, et al. Mass spectrometry meets chip technology: a new proteomic tool in cancer research?. Electrophoresis 2001; 22: 2898–902
   PubMed Web of Science ®Google Scholar
• Wadsworth JT, Somers KD, Stack BC, Jr, Cazares L, Malik G, Adam BL, et al. Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg 2004; 130: 98–104
   PubMed Web of Science ®Google Scholar
• Soltys SG, Le QT, Shi G, Tibshirani R, Giaccia AJ, Koong AC. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res 2004; 10: 4806–12
   PubMed Web of Science ®Google Scholar
• Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001; 158: 1491–502
   PubMed Web of Science ®Google Scholar
• Zhang YF, Wu DL, Guan M, Liu WW, Wu Z, Chen YM, et al. Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient. Clin Biochem 2004; 37: 772–9
   PubMed Web of Science ®Google Scholar
• Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002; 62: 3609–14
   PubMed Web of Science ®Google Scholar
• Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, et al. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res 2002; 8: 2541–52
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572–7
   PubMed Web of Science ®Google Scholar
• Vlahou A, Schorge JO, Gregory BW, Coleman RL. Diagnosis of ovarian cancer using decision tree classification of mass spectral data. J Biomed Biotechnol 2003; 2003: 308–14
   PubMedGoogle Scholar
• Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002; 48: 1296–304
   PubMed Web of Science ®Google Scholar
• Vlahou A, Laronga C, Wilson L, Gregory B, Fournier K, McGaughey D, et al. A novel approach toward development of a rapid blood test for breast cancer. Clin Breast Cancer 2003; 4: 203–9
   PubMedGoogle Scholar
• Poon TC, Yip TT, Chan AT, Yip C, Yip V, Mok TS, et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 2003; 49: 752–60
   PubMed Web of Science ®Google Scholar
• Xiao X, Liu D, Tang Y, Guo F, Xia L, Liu J, et al. Development of proteomic patterns for detecting lung cancer. Dis Markers -2004 2003; 19: 33–9
   Google Scholar
• Zhukov TA, Johanson RA, Cantor AB, Clark RA, Tockman MS. Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer 2003; 40: 267–79
   PubMed Web of Science ®Google Scholar
• Yu Y, Chen S, Wang LS, Chen WL, Guo WJ, Yan H, et al. Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology 2005; 68: 79–86
   PubMed Web of Science ®Google Scholar
• Kuropkat C, Rudolph P, Parwaresch R, Werner JA. Ki-S1 a prognostic marker for hypopharyngeal carcinoma with potential predictive value for response to chemotherapy. Anticancer Res 2003; 23: 3965–70
   PubMed Web of Science ®Google Scholar
• Chien CY, Huang CC, Cheng JT, Chen CM, Hwang CF, Su CY. The clinicopathological significance of p53 and p21 expression in squamous cell carcinoma of hypopharyngeal cancer. Cancer Lett 2003; 201: 217–23
   PubMed Web of Science ®Google Scholar
• Mineta H, Miura K, Takebayashi S, Misawa K, Araki K, Misawa Y, et al. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma. Anticancer Res 2002; 22: 3489–94
   PubMed Web of Science ®Google Scholar
• Paradis V, Degos F, Dargere D, Pham N, Belghiti J, Degott C, et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 2005; 41: 40–7
   PubMed Web of Science ®Google Scholar
• Diamandis EP. Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?. Clin Chem 2003; 49: 1272–5
   PubMed Web of Science ®Google Scholar